Properties (60)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
pharmaceutical drug
|
| gptkbp:analyzes |
filed
ongoing trials |
| gptkbp:chemicalFormula |
small molecule
|
| gptkbp:clinicalTrials |
gptkb:United_States
gptkb:wet_AMD Phase 2 Phase 3 varied demographics under investigation randomized controlled trial not yet established pending publication Mast Therapeutics awaiting analysis |
| gptkbp:collaborations |
academic institutions
|
| gptkbp:community_service |
not established
visual function |
| gptkbp:contraindication |
rare
|
| gptkbp:currentStatus |
completed
|
| gptkbp:customerFeedback |
collected during trials
|
| gptkbp:developedBy |
Mast Therapeutics
|
| gptkbp:dosageForm |
monthly
|
| gptkbp:futurePlans |
promising
|
| gptkbp:hasPopulation |
adults
|
| gptkbp:hasVariants |
with anti-VEGF agents
|
| gptkbp:healthcare |
specific criteria
required during trials |
| https://www.w3.org/2000/01/rdf-schema#label |
Fovista
|
| gptkbp:impact |
varies
limited to clinical trials |
| gptkbp:issuedBy |
ophthalmologist
|
| gptkbp:market |
high
|
| gptkbp:marketedAs |
Fovista_name
|
| gptkbp:patentStatus |
patented
|
| gptkbp:productionCompany |
late stage
|
| gptkbp:regulatoryCompliance |
planned
not_approved_by_FDA |
| gptkbp:research |
private investment
|
| gptkbp:research_areas |
anti-angiogenic agents
ophthalmic therapeutics |
| gptkbp:researchAndDevelopment |
improved visual acuity
potential for market approval |
| gptkbp:researchFocus |
retinal diseases
|
| gptkbp:researchInterest |
ongoing
clinical trials regulatory hurdles compliance required potentially significant evaluate safety and efficacy forthcoming |
| gptkbp:route |
intravitreal injection
|
| gptkbp:safetyFeatures |
under evaluation
|
| gptkbp:sideEffect |
ocular inflammation
|
| gptkbp:status |
investigational
|
| gptkbp:supplyChain |
under development
|
| gptkbp:targetMarket |
ophthalmology
|
| gptkbp:targets |
macular degeneration
|
| gptkbp:triggerType |
inhibits complement pathway
|
| gptkbp:usedFor |
treatment of wet age-related macular degeneration
|